Nature Communications (Oct 2022)

A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing

  • Miguel Vizoso,
  • Colin E. J. Pritchard,
  • Lorenzo Bombardelli,
  • Bram van den Broek,
  • Paul Krimpenfort,
  • Roderick L. Beijersbergen,
  • Kees Jalink,
  • Jacco van Rheenen

DOI
https://doi.org/10.1038/s41467-022-33863-z
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

Achieving spatial control of gene expression is important. Here the authors report an optimised photoactivatable Cre recombinase system, doxycycline- and light-inducible Cre recombinase (DiLiCre), and generate a DiLiCre mouse line which they use for mutagenesis in vivo and positional cell-tracing.